Brief Description
BreezeBio develops innovative therapies through targeted delivery of genetic medicines. The company's founders share the vision that recent scientific advancements in engineering CRISPR components and delivery vehicles offer a groundbreaking opportunity to develop safe and effective medicines for genetic diseases.
The company's proprietary Polymer nanoparticle can deliver CRISPR protein and gRNA. CRISPR in a protein form has many advantages, delivery has been a challenge limiting its application. To deliver CRISPR protein, encapsulation of CRISPR ribonucleoprotein (RNP) and efficient uptake by target cell need to be achieved. BreezeBio solves the challenge with its proprietary polymer nanoparticle platform.
Formerly known as GenEdit.
Inventors
Kunwoo Lee, Irina Conboy, Michael Conboy, Niren Murthy
Company Founders
Kunwoo Lee (UC Berkeley, Ph.D. ’16, Doctor of Philosophy), Hyo Park (UC Berkeley, Ph.D., Doctor of Philosophy)
Timeline
- 2016. Company founded.